MAPK1 and breast cancer: Additionally, myricetin was described to reduce the viability of human BC MCF-7 cells, at least in part, by promoting apoptosis through modulation of the PAK1/MEK/ERK/GSK3β/β-catenin/cyclin D1/PCNA/survivin/Bax-caspase-3 signaling pathway [94].